AMLX Other Income/Expenses (Net)
Amylyx Pharmaceuticals Inc · Other Income/Expenses (Net)
AMLX Other Income/Expenses (Net)
Latest reported$10.06Mperiod ending
AMLX TTM Other Income/Expenses (Net) (-$5.21M → $10.06M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
AMLX other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 10,057,000 | |
| 9,201,000 | |
| 8,602,000 | |
| 7,424,000 | |
| 8,740,000 | |
| -11,939,000 | |
| -10,256,000 | |
| -8,187,000 | |
| -7,453,000 | |
| 15,618,000 | |
| 15,495,000 | |
| 13,421,000 | |
| 10,530,000 | |
| 7,084,000 | |
| 3,740,000 | |
| 1,243,000 | |
| 219,000 | |
| -3,476,000 | |
| -5,243,000 | |
| -5,214,000 |